Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: A prospective cohort study

Inflammation

Volumn 33, Issue 6, 2010, Pages 374-380

  Rabna, Paulo ^a   Andersen, Andreas ^a   Wejse, Christian ^a,b   Oliveira, Ines ^a,c   Francisco Gomes, Victor ^a   Bonde Haaland, Maya ^c   Aaby, Peter ^a,d   Eugen Olsen, Jesper ^c  

^a Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

ATBneg; Guinea Bissau; Mortality; P suPAR; Prognostic; U suPAR

Indexed keywords

UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; COMPARATIVE STUDY; CONSULTATION; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; URINALYSIS; URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; COMMUNICABLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RISK; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUBERCULOSIS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 78549265781     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-010-9195-2     Document Type: Article

References (16)

1. P Rabna A Andersen C Wejse, et al. 2009 High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test Tropical Medicine and International Health 14 9 986 94 10.1111/j.1365-3156.2009. 02328.x 19725925
2. N Sidenius CF Sier H Ullum, et al. 2000 Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection Blood 96 13 4091 5 1:CAS:528:DC%2BD3cXosl2hsbg%3D 11110678
3. SR Ostrowski T Piironen G Hoyer-Hansen J Gerstoft BK Pedersen H Ullum 2005 High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients Journal of Acquired Immune Deficiency Syndromes 39 1 23 31 1:CAS:528:DC%2BD2MXjsFKgt7Y%3D 10.1097/01.qai.0000157950.02076.a6 15851910 (Pubitemid 40617015)
4. J Eugen-Olsen P Gustafson N Sidenius, et al. 2002 The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau International Journal of Tuberculosis and Lung Disease 6 8 686 92 1:STN:280: DC%2BD38vgtFOisA%3D%3D 12150480
5. P Wittenhagen G Kronborg N Weis, et al. 2004 The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality Clinical Microbiology and Infection 10 5 409 15 1:CAS:528:DC%2BD2cXkvFCntrw%3D 10.1111/j.1469-0691.2004.00850.x 15113317 (Pubitemid 38714567)
6. K Kofoed J Eugen-Olsen J Petersen K Larsen O Andersen 2008 Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor European Journal of Clinical Microbiology and Infectious Diseases 27 5 375 83 1:CAS:528:DC%2BD1cXlt1CqsLc%3D 10.1007/s10096-007-0447-5
7. FJ Olson TT Sorensen M Ryndel G Hoyer-Hansen B Fagerberg 2010 Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability Clinical Biochemistry 43 1-2 124 30 1:CAS:528:DC%2BC3cXoslaj 10.1016/j.clinbiochem.2009.09.028 19822140
8. N Sidenius F Blasi 2003 The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy Cancer and Metastasis Reviews 22 2-3 205 22 1:CAS:528:DC%2BD3sXis1CjtL8%3D 10.1023/A:1023099415940 12784997 (Pubitemid 36561058)
9. O Andersen J Eugen-Olsen K Kofoed J Iversen SB Haugaard 2008 Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy Journal of Medical Virology 80 2 209 16 1:CAS:528:DC%2BD1cXhtlyrtb0%3D 10.1002/jmv.21114 18098145
10. O Slot N Brunner H Locht P Oxholm RW Stephens 1999 Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis Annals of the Rheumatic Diseases 58 8 488 92 1:STN:280:DyaK1MzltVWjsg%3D%3D 10.1136/ard.58.8.488 10419867
11. B Fevang J Eugen-Olsen A Yndestad, et al. 2009 Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency Clinical Immunology 131 3 438 46 1:CAS:528:DC%2BD1MXmtVKksbY%3D 10.1016/j.clim.2009.01.007 19232508
12. N Sidenius CF Sier F Blasi 2000 Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo FEBS Letters 475 1 52 6 1:CAS:528:DC%2BD3cXktVSntL0%3D 10.1016/S0014-5793(00)01624-0 10854857 (Pubitemid 30331077)
13. CF Sier N Sidenius A Mariani, et al. 1999 Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance Laboratory Investigation 79 6 717 22 1:STN:280: DyaK1MzgsVymuw%3D%3D 10378514
14. K Kofoed UV Schneider T Scheel O Andersen J Eugen-Olsen 2006 Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology Clinical Chemistry 52 7 1284 93 1:CAS:528:DC%2BD28Xms1Wmsbs%3D 10.1373/clinchem.2006.067595 16690735 (Pubitemid 43956019)
15. CF Sier R Stephens J Bizik, et al. 1998 The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients Cancer Research 58 9 1843 9 1:CAS:528:DyaK1cXislentr8%3D 9581823
16. S Mustjoki N Sidenius CF Sier, et al. 2000 Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy Cancer Research 60 24 7126 32 1:CAS:528:DC%2BD3MXjsVOgsA%3D%3D 11156421